Compare MAGN & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAGN | MLAB |
|---|---|---|
| Founded | 1864 | 1982 |
| Country | United States | United States |
| Employees | 8500 | N/A |
| Industry | Paper | Industrial Machinery/Components |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 410.8M | 489.8M |
| IPO Year | N/A | 1995 |
| Metric | MAGN | MLAB |
|---|---|---|
| Price | $9.29 | $81.45 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $19.00 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 370.8K | 112.5K |
| Earning Date | 05-05-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 0.78% |
| EPS Growth | N/A | ★ 99.24 |
| EPS | N/A | ★ 1.95 |
| Revenue | N/A | N/A |
| Revenue This Year | $4.09 | $6.07 |
| Revenue Next Year | $2.34 | $5.41 |
| P/E Ratio | ★ N/A | $42.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.82 | $59.63 |
| 52 Week High | $19.21 | $130.12 |
| Indicator | MAGN | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 15.59 | 41.90 |
| Support Level | $8.93 | $77.23 |
| Resistance Level | $15.14 | $81.62 |
| Average True Range (ATR) | 0.49 | 4.15 |
| MACD | -0.18 | -0.73 |
| Stochastic Oscillator | 2.71 | 39.28 |
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.